We are live on ! Find out more
BC

Bartlett & Co Portfolio holdings

AUM $6.16B
1-Year Est. Return 20.29%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
10 Year Est. Return
AUM
$5.18B
AUM Growth
+$207M
Cap. Flow
-$4.51M
Cap. Flow %
-0.09%
Top 10 Hldgs %
29.67%
Holding
1,139
New
23
Increased
112
Reduced
262
Closed
63

Top Buys

Rank Stock Value
1
CFR icon
Cullen/Frost Bankers
CFR
+$15.6M
2
INTU icon
Intuit
INTU
+$10.2M
3
ZTS icon
Zoetis
ZTS
+$5.63M
4
AMZN icon
Amazon
AMZN
+$3.75M
5
QCOM icon
Qualcomm
QCOM
+$3.57M

Sector Composition

Rank Sector Weight
1 Technology 18.68%
2 Healthcare 12.92%
3 Financials 10.89%
4 Industrials 9.64%
5 Consumer Staples 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOG icon
926
Harley-Davidson
HOG
$2.74B
$3K ﹤0.01%
80
NWSA icon
927
News Corp Class A
NWSA
$14.4B
$3K ﹤0.01%
159
PBW icon
928
Invesco WilderHill Clean Energy ETF
PBW
$399M
$3K ﹤0.01%
+74
New +$3.11K
PCG icon
929
PG&E
PCG
$47.4B
$3K ﹤0.01%
200
SU icon
930
Suncor Energy
SU
$78.4B
$3K ﹤0.01%
100
TLRY icon
931
Tilray
TLRY
$481M
$3K ﹤0.01%
112
TPR icon
932
Tapestry
TPR
$28B
$3K ﹤0.01%
60
TRU icon
933
TransUnion
TRU
$14.5B
$3K ﹤0.01%
45
-45
-50% -$2.94K
USA icon
934
Liberty All-Star Equity Fund
USA
$1.74B
$3K ﹤0.01%
558
WBS.PRG icon
935
Webster Financial Corp 6.50% Series G Preferred Stock
WBS.PRG
$126M
$3K ﹤0.01%
150
WW
936
DELISTED
WW International
WW
$3K ﹤0.01%
800
VRTV
937
DELISTED
VERITIV CORPORATION
VRTV
$3K ﹤0.01%
24
ZIVO
938
DELISTED
Zivo Bioscience, Inc. Common Stock
ZIVO
$3K ﹤0.01%
167
NWBO
939
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$3K ﹤0.01%
4,292
BAC.PRL icon
940
Bank of America Series L
BAC.PRL
$3.95B
0
BH.A icon
941
Biglari Holdings Class A
BH.A
$1.25B
$2K ﹤0.01%
2
BST icon
942
BlackRock Science and Technology Trust
BST
$1.58B
$2K ﹤0.01%
75
CCL icon
943
Carnival Corporation Ltd
CCL
$35.7B
$2K ﹤0.01%
200
EMLC icon
944
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.74B
$2K ﹤0.01%
+75
New +$1.86K
HII icon
945
Huntington Ingalls Industries
HII
$11.4B
$2K ﹤0.01%
12
IFF icon
946
International Flavors & Fragrances
IFF
$19B
$2K ﹤0.01%
23
-300
-93% -$29.8K
IWY icon
947
iShares Russell Top 200 Growth ETF
IWY
$16B
$2K ﹤0.01%
13
IX icon
948
ORIX
IX
$43.8B
$2K ﹤0.01%
115
JBGS
949
JBG SMITH
JBGS
$843M
$2K ﹤0.01%
115
KTB icon
950
Kontoor Brands
KTB
$4.61B
$2K ﹤0.01%
35

Similar funds

Bartlett & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Bartlett & Co held 1,139 positions worth $5.18B, up 4.2% from $4.97B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bartlett & Co's Q1 2023 filing shows 23 new, 112 increased, 262 reduced and 63 closed positions. Its largest new stake was GE HealthCare: 1,997 shares worth $164K. The largest sale was Baxter International, an estimated $10.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Bartlett & Co's largest Q1 2023 buy was GE HealthCare: 1,997 shares worth $164K.
  • Bartlett & Co added most to Cullen/Frost Bankers in Q1 2023, an estimated $15.6M increase.
  • Bartlett & Co's biggest Q1 2023 reduction was Baxter International, cutting an estimated $10.2M.
  • Bartlett & Co fully exited Charles Schwab 5.95% Series D Preferred Stock in Q1 2023, selling an estimated $205K.
  • Bartlett & Co's ten largest holdings make up 30% of its $5.18B portfolio in Q1 2023.
  • Bartlett & Co opened 23 new positions and closed 63 in Q1 2023.
  • Bartlett & Co's portfolio value rose 4.2% quarter-over-quarter to $5.18B.

Based on Bartlett & Co's 13F filing for Q1 2023, filed 6 Apr 2023.